Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,771 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
Chauhan SC, Vannatta K, Ebeling MC, Vinayek N, Watanabe A, Pandey KK, Bell MC, Koch MD, Aburatani H, Lio Y, Jaggi M. Chauhan SC, et al. Among authors: watanabe a. Cancer Res. 2009 Feb 1;69(3):765-74. doi: 10.1158/0008-5472.CAN-08-0587. Epub 2009 Jan 27. Cancer Res. 2009. PMID: 19176398
MUC13 mucin augments pancreatic tumorigenesis.
Chauhan SC, Ebeling MC, Maher DM, Koch MD, Watanabe A, Aburatani H, Lio Y, Jaggi M. Chauhan SC, et al. Among authors: watanabe a. Mol Cancer Ther. 2012 Jan;11(1):24-33. doi: 10.1158/1535-7163.MCT-11-0598. Epub 2011 Oct 25. Mol Cancer Ther. 2012. PMID: 22027689 Free PMC article.
Increased expression and aberrant localization of mucin 13 in metastatic colon cancer.
Gupta BK, Maher DM, Ebeling MC, Sundram V, Koch MD, Lynch DW, Bohlmeyer T, Watanabe A, Aburatani H, Puumala SE, Jaggi M, Chauhan SC. Gupta BK, et al. Among authors: watanabe a. J Histochem Cytochem. 2012 Nov;60(11):822-31. doi: 10.1369/0022155412460678. Epub 2012 Aug 20. J Histochem Cytochem. 2012. PMID: 22914648 Free PMC article.
Overexpression of MUC13 is associated with intestinal-type gastric cancer.
Shimamura T, Ito H, Shibahara J, Watanabe A, Hippo Y, Taniguchi H, Chen Y, Kashima T, Ohtomo T, Tanioka F, Iwanari H, Kodama T, Kazui T, Sugimura H, Fukayama M, Aburatani H. Shimamura T, et al. Among authors: watanabe a. Cancer Sci. 2005 May;96(5):265-73. doi: 10.1111/j.1349-7006.2005.00043.x. Cancer Sci. 2005. PMID: 15904467 Free PMC article.
Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
Ito H, Funahashi S, Yamauchi N, Shibahara J, Midorikawa Y, Kawai S, Kinoshita Y, Watanabe A, Hippo Y, Ohtomo T, Iwanari H, Nakajima A, Makuuchi M, Fukayama M, Hirata Y, Hamakubo T, Kodama T, Tsuchiya M, Aburatani H. Ito H, et al. Among authors: watanabe a. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3257-64. doi: 10.1158/1078-0432.CCR-05-2787. Clin Cancer Res. 2006. PMID: 16740745
Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, Taniguchi H, Ishikawa S, Ito H, Yamamoto S, Iwanari H, Hironaka M, Ishikawa Y, Niki T, Sohara Y, Kodama T, Nishimura M, Fukayama M, Dosaka-Akita H, Aburatani H. Fukumoto S, et al. Among authors: watanabe a. Clin Cancer Res. 2005 Mar 1;11(5):1776-85. doi: 10.1158/1078-0432.CCR-04-1238. Clin Cancer Res. 2005. PMID: 15755999
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.
Hippo Y, Watanabe K, Watanabe A, Midorikawa Y, Yamamoto S, Ihara S, Tokita S, Iwanari H, Ito Y, Nakano K, Nezu J, Tsunoda H, Yoshino T, Ohizumi I, Tsuchiya M, Ohnishi S, Makuuchi M, Hamakubo T, Kodama T, Aburatani H. Hippo Y, et al. Among authors: watanabe k, watanabe a. Cancer Res. 2004 Apr 1;64(7):2418-23. doi: 10.1158/0008-5472.can-03-2191. Cancer Res. 2004. PMID: 15059894
4,771 results